GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » EV-to-FCF

Fulgent Genetics (MEX:FLGT) EV-to-FCF : -15.50 (As of Apr. 01, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Fulgent Genetics's Enterprise Value is MXN5,463 Mil. Fulgent Genetics's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was MXN-352 Mil. Therefore, Fulgent Genetics's EV-to-FCF for today is -15.50.

The historical rank and industry rank for Fulgent Genetics's EV-to-FCF or its related term are showing as below:

MEX:FLGT' s EV-to-FCF Range Over the Past 10 Years
Min: -1069.23   Med: 2.97   Max: 361.33
Current: -14.15

During the past 11 years, the highest EV-to-FCF of Fulgent Genetics was 361.33. The lowest was -1069.23. And the median was 2.97.

MEX:FLGT's EV-to-FCF is ranked worse than
100% of 106 companies
in the Medical Diagnostics & Research industry
Industry Median: 26.18 vs MEX:FLGT: -14.15

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-01), Fulgent Genetics's stock price is MXN330.00. Fulgent Genetics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was MXN-26.078. Therefore, Fulgent Genetics's PE Ratio (TTM) for today is At Loss.


Fulgent Genetics EV-to-FCF Historical Data

The historical data trend for Fulgent Genetics's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics EV-to-FCF Chart

Fulgent Genetics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.22 5.07 1.67 92.90 -16.41

Fulgent Genetics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.90 19.61 24.86 -15.91 -16.41

Competitive Comparison of Fulgent Genetics's EV-to-FCF

For the Diagnostics & Research subindustry, Fulgent Genetics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fulgent Genetics's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's EV-to-FCF falls into.


;
;

Fulgent Genetics EV-to-FCF Calculation

Fulgent Genetics's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=5462.592/-352.45
=-15.50

Fulgent Genetics's current Enterprise Value is MXN5,463 Mil.
Fulgent Genetics's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-352 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fulgent Genetics  (MEX:FLGT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Fulgent Genetics's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=330.00/-26.078
=At Loss

Fulgent Genetics's share price for today is MXN330.00.
Fulgent Genetics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-26.078.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Fulgent Genetics EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Fulgent Genetics Business Description

Traded in Other Exchanges
Address
4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.